Governance Frequently Asked Questions

ASMBS remains focused on supporting its members, advancing the specialty, and improving access to effective obesity treatment. The following information addresses recent leadership changes and the Society’s priorities moving forward.

The ASMBS Board of Directors held a special meeting on November 17, 2026, to address governance and leadership matters. Following the meeting, Dr. C. Joe Northup concluded his service as President and as a member of the Board of Directors. Dr. Tammy Kindel also concluded her Board service. ASMBS appreciates both surgeons’ contributions to the organization and the specialty.

The meeting was convened in accordance with the ASMBS bylaws to consider matters involving governance, organizational oversight, and leadership. The Board addressed the matters identified in the meeting notice and took action concerning elected leadership. ASMBS will communicate the resulting leadership changes and organizational next steps while maintaining the confidentiality of Board deliberations and individual matters.

ASMBS recognizes the importance of membership elections and the trust members place in those they elect to represent them. The Society’s bylaws establish both the process for electing leaders and the Board of Directors’ authority to address governance matters throughout an elected term. Section 5.21.1 gives the Board authority to remove a director when it determines it is in the Society’s best interest. This authority is part of the governance structure the Society adopted and does not diminish the importance of membership elections or the contributions of elected leaders.

The November 17 special meeting was convened under Section 5.13 of the bylaws, and leadership changes were addressed through the Board’s governance process. The Board recognizes the significance of these decisions and its responsibility to the membership for ASMBS’s continued leadership and stewardship.

ASMBS recognizes that members want to understand the circumstances surrounding significant leadership changes, particularly those involving individuals elected by the membership. The November 17 special meeting addressed matters involving corporate governance, organizational oversight, and leadership responsibilities. The Board is responsible for acting in the Society’s best interests and exercising the authority established in its governing documents. Certain information considered during Board deliberations is confidential and cannot be shared publicly.

The Society will continue to provide information about the actions taken, the governance provisions applicable to those actions, leadership succession, and the steps being taken to maintain appropriate oversight and organizational continuity. We recognize that transparency is important to maintaining the membership’s confidence. We are committed to sharing information that can be made public while respecting confidentiality obligations and the individuals involved.

Pursuant to Bylaws 6.03 & 6.07, Dr. Rana Pullatt will serve as ASMBS President for the remainder of the 2026-27 term. He will remain President through the originally elected term concluding on June 30, 2028. The Society will maintain an updated leadership directory on its website.

The Board will follow the applicable procedures established in the ASMBS bylaws for addressing vacancies and leadership succession. The Director-at-Large vacancy will be filled as outlined in Bylaws 6.07. Any appointments or elections requiring additional action will be communicated to members.

Members may review the current ASMBS Amended and Restated Bylaws online. The special meeting notice referenced Sections 5.13, 5.03, and 5.21.1, concerning special Board meetings and the removal of officers and directors.

Yes. ASMBS remains operational, and its educational programs, advocacy work, research initiatives, professional development opportunities, and member services continue. The executive team and volunteer leadership will coordinate any necessary adjustments to committee assignments or organizational responsibilities.

The leadership transition does not, by itself, change ASMBS’s established strategic priorities. Our focus remains on strengthening the specialty, improving patient access, supporting our members, and advancing comprehensive obesity care.

ASMBS remains committed to the strategic priorities that support the specialty and the patients we serve. The Society recognizes the challenges facing metabolic and bariatric surgery, including declining surgical volumes, evolving referral patterns, access and coverage barriers, and the increasing use of obesity management medications. The leadership transition does not automatically discontinue initiatives developed under the previous presidency. The Society will continue to evaluate and evolve existing initiatives through its established planning and governance processes to maintain continuity, assess progress, and identify opportunities to strengthen implementation.

Our continuing priorities include:

  • Improving patient access to metabolic and bariatric surgery through advocacy, payer engagement, and evidence-based coverage policies.
  • Strengthening the integration of surgery, obesity management medications, and other treatments within comprehensive obesity care.
  • Advancing research and communicating the clinical effectiveness, safety, and long-term outcomes of metabolic and bariatric surgery.
  • Supporting the metabolic and bariatric surgery workforce, quality improvement, accreditation, and practice sustainability.
  • Expanding education, professional development, and practical resources for members.
  • Increasing public and professional understanding of obesity treatment and the appropriate role of surgery.

ASMBS recognizes the challenges facing the specialty, including changing treatment patterns, the growing use of anti-obesity medications, coverage limitations, and evolving referral pathways. The Society will continue advocating for evidence-based care, supporting clinical education, strengthening professional collaboration, and advancing policies that improve access to metabolic and bariatric surgery when appropriate.

Yes. ASMBS recognizes obesity as a complex, progressive chronic disease requiring individualized, evidence-based treatment. Surgery, anti-obesity medications, nutritional care, behavioral interventions, and other appropriate treatments all have important roles. ASMBS will continue working to connect patients with appropriate clinical expertise and treatment options throughout their care.

Yes. ASMBS values its relationships with professional societies, patient advocacy organizations, industry collaborators, and other organizations advancing obesity care. Existing partnerships and initiatives will continue to be managed through the Society’s established organizational processes. Any changes in designated leadership contacts will be communicated directly to the affected organizations.

ASMBS will coordinate any required changes to committee or project leadership while supporting the continuation of approved work. Research activities, publications, and editorial responsibilities will be managed according to applicable agreements, policies, and scholarly standards.

The Society’s immediate priorities are to confirm leadership succession, address Board vacancies, maintain operational continuity, support ongoing initiatives, and communicate any material changes to members and partners. ASMBS will provide additional information through official communication channels as leadership appointments and other material organizational changes are confirmed. All communications will also be posted in the ASMBS Governance Hub.

Members may contact governance@asmbs.org or visit the ASMBS Governance Hub for further information regarding the leadership transition, membership services, or ongoing Society activities. ASMBS will respond to appropriate questions while respecting confidential governance and individual matters.

 

ASMBS remains committed to supporting the professionals who deliver metabolic and bariatric care and the patients whose lives depend on access to effective treatment.

American Society for Metabolic and Bariatric Surgery
On behalf of the ASMBS Board of Directors